唯捷創芯(688153.SH):新一代高集成度模組Phase 7LE Plus在性能上取得了顯著突破
格隆匯5月22日丨唯捷創芯(688153.SH)在互動平臺表示,公司所擁有的專利均爲自主研發成果,我們在技術研發方面一直保持着獨立自主的創新精神,致力於通過自身的技術積累和創新突破來提升產品性能與競爭力。公司新一代高集成度模組Phase 7LE Plus在性能上取得了顯著突破,其部分技術指標已達到行業領先水平。目前,該模組已經獲得了品牌手機客戶的旗艦機型訂單,這標誌着我們在高端市場取得了重要進展,塑造了新的營收增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.